🇺🇸 FDA
Patent

US 12351824

Method for producing natural killer cells from pluripotent stem cells

granted A61KA61K2239/31A61K2239/38

Quick answer

US patent 12351824 (Method for producing natural killer cells from pluripotent stem cells) held by Takeda Pharmaceutical Company Limited expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Jul 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K2239/31, A61K2239/38, A61K2239/48, A61K40/15